Givaudan logo

Givaudan

Last updated January 31, 2026
25
Innovation Areas
723
Inventors
10
Collaborations

Poor systemic curcuminoid bioavailability: GivaudanRecent Research Landscape

Curcuminoids suffer from low solubility and rapid metabolism which prevents therapeutic efficacy. Overcoming this limitation ensures active compounds reach target tissues to alleviate muscle soreness.